CVS Health Corporation (CVS)
CVS Health Corporation is an American healthcare company that operates retail pharmacies, a pharmacy benefit management (PBM) business, and a retail healthcare clinic business. The company is known for its retail pharmacy chains, including CVS Pharmacy and Longs Drugs, and its PBM business, CVS Caremark. It is one of the largest pharmacy healthcare providers in the United States, with more than 9,900 stores.
Company Info
Highlights
$81.99B
$4.19
15.47
0.73
$378.96B
$53.24B
$14.82B
$42.57 - $72.51
$79.17
1.31%
1.45
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
CVS Health Corporation (CVS) returned 37.89% year-to-date (YTD) and 12.09% over the past 12 months. Over the past 10 years, CVS returned -2.35% annually, underperforming the S&P 500 benchmark at 10.77%.
CVS
37.89%
-12.06%
14.57%
12.09%
2.64%
-2.35%
^GSPC (Benchmark)
0.08%
9.75%
-1.63%
12.74%
15.66%
10.77%
Monthly Returns
The table below presents the monthly returns of CVS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 27.42% | 16.36% | 3.09% | -0.52% | -9.31% | 37.89% | |||||||
| 2024 | -4.96% | -0.00% | 7.25% | -14.29% | -11.98% | -0.91% | 3.30% | -5.12% | 9.85% | -9.21% | 6.00% | -25.00% | -40.77% |
| 2023 | -4.68% | -5.30% | -11.05% | -0.53% | -7.20% | 1.62% | 8.93% | -12.75% | 7.14% | -0.31% | -1.54% | 16.20% | -12.53% |
| 2022 | 3.80% | -2.69% | -2.35% | -4.53% | 0.65% | -4.23% | 3.86% | 2.58% | -2.83% | -0.10% | 7.58% | -8.53% | -7.63% |
| 2021 | 5.61% | -4.91% | 10.42% | 2.22% | 13.14% | -3.47% | -0.70% | 4.89% | -1.77% | 5.82% | -0.25% | 15.83% | 54.87% |
| 2020 | -8.09% | -12.74% | 0.25% | 4.61% | 6.53% | -0.92% | -2.37% | -1.30% | -5.99% | -3.14% | 20.86% | 0.75% | -5.14% |
| 2019 | 0.81% | -11.78% | -6.74% | 1.81% | -3.70% | 4.05% | 3.45% | 9.04% | 3.53% | 6.06% | 13.38% | -1.30% | 17.26% |
| 2018 | 9.21% | -13.93% | -8.15% | 13.11% | -9.22% | 1.51% | 1.56% | 16.00% | 4.63% | -7.41% | 10.79% | -18.30% | -7.04% |
| 2017 | 0.48% | 2.25% | -2.58% | 5.69% | -6.80% | 4.72% | -0.01% | -3.24% | 5.15% | -15.17% | 11.78% | -5.35% | -5.75% |
| 2016 | -0.76% | 0.60% | 6.75% | -2.71% | -4.03% | -0.74% | -2.73% | 0.73% | -4.72% | -5.03% | -8.57% | 2.63% | -17.83% |
| 2015 | 2.28% | 5.82% | -0.64% | -3.46% | 3.11% | 2.44% | 7.58% | -8.95% | -5.78% | 2.73% | -4.75% | 3.91% | 2.90% |
| 2014 | -4.99% | 8.00% | 2.35% | -2.50% | 7.70% | -3.77% | 1.68% | 4.05% | 0.18% | 8.18% | 6.47% | 5.42% | 36.56% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CVS is 62, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for CVS Health Corporation (CVS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
CVS Health Corporation provided a 4.40% dividend yield over the last twelve months, with an annual payout of $2.66 per share. The company has been increasing its dividends for 27 consecutive years, earning it the status of a dividend aristocrat.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.66 | $2.66 | $2.42 | $2.20 | $2.00 | $2.00 | $2.00 | $2.00 | $2.00 | $1.70 | $1.40 | $1.10 |
Dividend yield | 4.40% | 5.93% | 3.06% | 2.36% | 1.94% | 2.93% | 2.69% | 3.05% | 2.76% | 2.15% | 1.43% | 1.14% |
Monthly Dividends
The table displays the monthly dividend distributions for CVS Health Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.67 | $0.00 | $0.00 | $0.67 | $0.00 | $1.33 | |||||||
| 2024 | $0.67 | $0.00 | $0.00 | $0.67 | $0.00 | $0.00 | $0.67 | $0.00 | $0.00 | $0.67 | $0.00 | $0.00 | $2.66 |
| 2023 | $0.61 | $0.00 | $0.00 | $0.61 | $0.00 | $0.00 | $0.61 | $0.00 | $0.00 | $0.61 | $0.00 | $0.00 | $2.42 |
| 2022 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $2.20 |
| 2021 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $2.00 |
| 2020 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $2.00 |
| 2019 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $2.00 |
| 2018 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $2.00 |
| 2017 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $2.00 |
| 2016 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $1.70 |
| 2015 | $0.35 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $1.40 |
| 2014 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $1.10 |
Dividend Yield & Payout
Dividend Yield
CVS Health Corporation has a dividend yield of 4.40%, which is quite average when compared to the overall market.
Payout Ratio
CVS Health Corporation has a payout ratio of 41.82%, which is quite average when compared to the overall market. This suggests that CVS Health Corporation strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the CVS Health Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the CVS Health Corporation was 64.07%, occurring on Jan 30, 2003. Recovery took 614 trading sessions.
The current CVS Health Corporation drawdown is 38.90%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -64.07% | Mar 9, 2001 | 474 | Jan 30, 2003 | 614 | Jul 8, 2005 | 1088 |
| -56.79% | Feb 9, 2022 | 720 | Dec 19, 2024 | — | — | — |
| -50.11% | Feb 25, 1999 | 261 | Mar 7, 2000 | 173 | Nov 9, 2000 | 434 |
| -50.09% | Jul 30, 2015 | 925 | Apr 2, 2019 | 654 | Nov 3, 2021 | 1579 |
| -45.26% | Jun 6, 2008 | 190 | Mar 9, 2009 | 721 | Jan 17, 2012 | 911 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of CVS Health Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of CVS Health Corporation, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 34.6% positive surprise.
Valuation
The Valuation section provides an overview of how CVS Health Corporation is priced in the market compared to other companies in the Healthcare Plans industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CVS, comparing it with other companies in the Healthcare Plans industry. Currently, CVS has a P/E ratio of 15.5. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for CVS compared to other companies in the Healthcare Plans industry. CVS currently has a PEG ratio of 0.7. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CVS relative to other companies in the Healthcare Plans industry. Currently, CVS has a P/S ratio of 0.2. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CVS in comparison with other companies in the Healthcare Plans industry. Currently, CVS has a P/B value of 1.1. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |